JP2008546376A5 - - Google Patents

Download PDF

Info

Publication number
JP2008546376A5
JP2008546376A5 JP2008516076A JP2008516076A JP2008546376A5 JP 2008546376 A5 JP2008546376 A5 JP 2008546376A5 JP 2008516076 A JP2008516076 A JP 2008516076A JP 2008516076 A JP2008516076 A JP 2008516076A JP 2008546376 A5 JP2008546376 A5 JP 2008546376A5
Authority
JP
Japan
Prior art keywords
seq
nucleic acid
acid molecule
change
epilepsy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008516076A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008546376A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2006/000841 external-priority patent/WO2006133508A1/en
Publication of JP2008546376A publication Critical patent/JP2008546376A/ja
Publication of JP2008546376A5 publication Critical patent/JP2008546376A5/ja
Pending legal-status Critical Current

Links

JP2008516076A 2005-06-16 2006-06-16 Ｓｃｎ１ａ遺伝子における変異を検出することによっててんかんを診断および処置するための方法 Pending JP2008546376A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005903146A AU2005903146A0 (en) 2005-06-16 Methods for the diagnosis and treatment of epilepsy
PCT/AU2006/000841 WO2006133508A1 (en) 2005-06-16 2006-06-16 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene

Publications (2)

Publication Number Publication Date
JP2008546376A JP2008546376A (ja) 2008-12-25
JP2008546376A5 true JP2008546376A5 (https=) 2009-07-30

Family

ID=37531886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008516076A Pending JP2008546376A (ja) 2005-06-16 2006-06-16 Ｓｃｎ１ａ遺伝子における変異を検出することによっててんかんを診断および処置するための方法

Country Status (6)

Country Link
US (1) US20100088778A1 (https=)
EP (1) EP1904630A4 (https=)
JP (1) JP2008546376A (https=)
CA (1) CA2612180A1 (https=)
NZ (1) NZ564892A (https=)
WO (1) WO2006133508A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003904154A0 (en) 2003-08-07 2003-08-21 Bionomics Limited Mutations in ion channels
JP2005501536A (ja) * 2001-07-18 2005-01-20 バイオノミックス リミテッド イオンチャネルにおける変異
AU2003901425A0 (en) * 2003-03-27 2003-04-10 Bionomics Limited A diagnostic method for epilepsy
JP5540343B2 (ja) * 2007-11-06 2014-07-02 国立大学法人 岡山大学 小児てんかん患者における急性脳炎または急性脳症の罹患リスク判定データの取得方法およびその利用
JP5608863B2 (ja) * 2007-12-28 2014-10-15 公立大学法人横浜市立大学 新生児期〜乳児期発症の難治性てんかんの検出方法
ES2904911T3 (es) * 2009-08-20 2022-04-06 Biosceptre Aust Pty Ltd Anticuerpos anti-receptor P2X7 y fragmentos de los mismos
JP5846372B2 (ja) * 2010-01-29 2016-01-20 国立大学法人 岡山大学 Ｄｒａｖｅｔ症候群の発症可能性の判定方法およびその利用
JP2011188837A (ja) * 2010-03-16 2011-09-29 Hirosaki Univ リーシークエンスｄｎａチップおよび最適抗てんかん薬決定方法
WO2011163499A2 (en) * 2010-06-23 2011-12-29 Opko Curna, Llc Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
TWI734935B (zh) * 2011-06-24 2021-08-01 美商可娜公司 上調電壓門控鈉離子通道第Ｉ型α次單元(ＳＣＮ１Ａ)之表現及/或功能之反義寡核苷酸及其用途
US9549909B2 (en) 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
KR102245345B1 (ko) 2014-09-29 2021-04-28 조게닉스 인터내셔널 리미티드 의약품 배포 제어를 위한 제어 시스템
CN108348527A (zh) * 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法
EP3933041B1 (en) * 2015-12-14 2024-01-31 Cold Spring Harbor Laboratory Antisense oligomers for treatment of autosomal dominant retardation
WO2017112701A1 (en) 2015-12-22 2017-06-29 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
PT4293009T (pt) 2015-12-22 2025-09-08 Zogenix International Ltd Composições de fenfluramina e métodos de preparação das mesmas
AU2017315273B2 (en) 2016-08-24 2021-04-29 Zogenix International Limited Formulation for inhibiting formation of 5-HT 2B agonists and methods of using same
US20210188839A1 (en) * 2016-11-28 2021-06-24 Praxis Precision Medicines, Inc. Compounds and their methods of use
DK3548033T3 (da) 2016-11-28 2024-07-15 Praxis Prec Medicines Inc Forbindelser og deres fremgangsmåde til anvendelse
US11261188B2 (en) 2016-11-28 2022-03-01 Praxis Precision Medicines, Inc. Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel
CN106719436A (zh) * 2016-12-20 2017-05-31 郑州伊美诺生物技术有限公司 一种制备单克隆抗体的小鼠模型建立方法
US11492345B2 (en) 2017-02-13 2022-11-08 Praxis Precision Medicines, Inc. Compounds and their methods of use
WO2018187480A1 (en) 2017-04-04 2018-10-11 Praxis Precision Medicines, Inc. Compounds and their methods of use
WO2018213491A1 (en) * 2017-05-16 2018-11-22 Praxis Precision Medicines, Inc. Methods of treating epilepsy and neurodevelopmental disorders
WO2019035951A1 (en) 2017-08-15 2019-02-21 Praxis Precision Medicines, Inc. COMPOUNDS AND THEIR METHODS OF USE
SG11202001590RA (en) 2017-08-25 2020-03-30 Stoke Therapeutics Inc Antisense oligomers for treatment of conditions and diseases
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
CA3085576A1 (en) 2017-12-13 2019-06-20 The Research Foundation For The State University Of New York Peptides and other agents for treating pain and increasing pain sensitivity
EP3790537A1 (en) 2018-05-11 2021-03-17 Zogenix International Limited Compositions and methods for treating seizure-induced sudden death
US12259378B2 (en) 2018-05-25 2025-03-25 Praxis Precision Medicines, Inc. Dynamic clamps and methods of use thereof
EP4465051A3 (en) * 2018-05-29 2025-01-22 Cognizance Biomarkers, Inc. Biomarkers and methods for evaluation and treatment of epileptic vs non-epileptic seizures / no seizures / psychogenic non-epileptic seizures
WO2019232209A1 (en) 2018-05-30 2019-12-05 Praxis Precision Medicines, Inc. Ion channel modulators
BR112021003224A2 (pt) 2018-08-20 2021-07-20 Rogcon, Inc. oligonucleotídeos antissentido direcionados a scn2a para o tratamento de encefalopatias por scn1a
EA202092908A1 (ru) 2018-09-28 2021-05-14 Праксис Пресижн Медсинз, Инк. Модуляторы ионных каналов
AU2019384963B2 (en) 2018-11-19 2022-05-26 Zogenix International Limited Methods of treating Rett syndrome using fenfluramine
KR20210134003A (ko) 2019-02-27 2021-11-08 스톡 테라퓨틱스, 인크. 병태 및 질환의 치료를 위한 안티센스 올리고머
US11773099B2 (en) 2019-05-28 2023-10-03 Praxis Precision Medicines, Inc. Compounds and their methods of use
US11505554B2 (en) 2019-05-31 2022-11-22 Praxis Precision Medicines, Inc. Substituted pyridines as ion channel modulators
US11279700B2 (en) 2019-05-31 2022-03-22 Praxis Precision Medicines, Inc. Ion channel modulators
US11767325B2 (en) 2019-11-26 2023-09-26 Praxis Precision Medicines, Inc. Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
US12552797B2 (en) 2019-11-27 2026-02-17 Praxis Precision Medicines, Inc. Process for making (3-[cyclopropylethoxy(difluoro)methyl]-6-6[5-fluoro-6-(2,2,2-trifluoroethoxy-3-pyridyl]- [1,2,4]triazolo[4,3-a]pyrazine
BR112022022889A2 (pt) 2020-05-11 2023-04-04 Stoke Therapeutics Inc Oligômeros antissentido de opa1 para tratamento de condições e doenças
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MX2024013240A (es) 2022-04-26 2024-12-06 Praxis Prec Medicines Inc Tratamiento de trastornos neurologicos
CN116024222B (zh) * 2022-11-30 2023-12-22 湖南家辉生物技术有限公司 一种导致婴儿严重肌阵挛性癫痫的nac1基因突变体及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4971903A (en) * 1988-03-25 1990-11-20 Edward Hyman Pyrophosphate-based method and apparatus for sequencing nucleic acids
US5331573A (en) * 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
US6331614B1 (en) * 1998-12-23 2001-12-18 Myriad Genetics, Inc. Human CDC14A gene
EP1252330A2 (en) * 1999-11-26 2002-10-30 McGill University Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
US6703439B2 (en) * 2000-02-09 2004-03-09 Mitsui Chemicals, Inc. Polyolefin resin composition and polyolefin film prepared from the same
AUPQ882600A0 (en) * 2000-07-18 2000-08-10 Bionomics Limited Mutations in ion channels
AUPR220300A0 (en) * 2000-12-20 2001-01-25 Bionomics Limited New epilepsy gene
US7709225B2 (en) * 2001-07-18 2010-05-04 Bionomics Limited Nucleic acids encoding mutations in sodium channels related to epilepsy
JP2005501536A (ja) * 2001-07-18 2005-01-20 バイオノミックス リミテッド イオンチャネルにおける変異
AU2003904154A0 (en) * 2003-08-07 2003-08-21 Bionomics Limited Mutations in ion channels
US7282336B2 (en) * 2001-07-18 2007-10-16 Bionomics Limited Method of diagnosing epilepsy
EP1474176A4 (en) * 2001-11-26 2005-06-15 Bristol Myers Squibb Co HUMAN G PROTEIN-COUPLED RECEPTOR, HGPRBMY31, VARIANTS AND METHODS OF USING THE SAME
AU2003901425A0 (en) * 2003-03-27 2003-04-10 Bionomics Limited A diagnostic method for epilepsy

Similar Documents

Publication Publication Date Title
JP2008546376A5 (https=)
AU2023226698B2 (en) Oligonucleotide probes and uses thereof
AU2023237051B2 (en) Oligonucleotide probes and uses thereof
JP2008249727A5 (https=)
JP2009533033A5 (https=)
JP2008546403A5 (https=)
CN102127819B (zh) Mhc区域核酸文库的构建方法及用途
JP2009523005A5 (https=)
CN110541025B (zh) 杜氏肌营养不良基因缺陷的检测方法、引物组合物及试剂盒
RU2009135270A (ru) Способы выявления воспалительного заболевания кишечника
WO2014189768A1 (en) Devices and methods for display of encoded peptides, polypeptides, and proteins on dna
CN102220434B (zh) 用于诊断非综合征耳聋的杂交膜条、pcr引物及试剂盒
Devarajan Genomic and proteomic characterization of acute kidney injury
JP2009518001A5 (https=)
WO2016042114A1 (en) Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis
CN105886605B (zh) Pkd2基因突变检测的扩增引物及检测方法
CN1659280A (zh) La1－乳杆菌属菌株的基因组
US10939868B2 (en) Method of predicting rapid progression of fibrosis and therapy and reagents therefor
JP2004201692A5 (https=)
WO2011014989A1 (zh) 靶向结核分枝杆菌Ag85B的寡核苷酸适配子及其制备方法和应用
JP2004290197A5 (https=)
CN102296105A (zh) 一种检测mlh1基因突变的方法及其试剂盒
CN103555833A (zh) 家族性遗传性鼻出血致病基因突变检测试剂盒及应用
CN104250649B (zh) 皮肤角化‑少毛‑白甲综合征新的致病基因及其编码蛋白质和应用
JP2005528910A5 (https=)